CAPR
CAPRICOR THERAPEUTICS, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.06
−3.82%0
Insider buys (3m)
4
Insider sells (3m)
-$1.5M
Net value (3m)
-68.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Jun 29, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | Sale | 24,100 | $30 |
| Jun 29, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | Sale | 24,100 | $30 |
| Jun 29, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 24,100 | $3.18 |
| Jun 29, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 24,100 | $3.18 |
| Jun 24, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 400 | $3.18 |
| Jun 24, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | Sale | 400 | $30 |
| Jun 24, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 500 | $3.18 |
| Jun 24, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 500 | $3.18 |
| Jun 24, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 400 | $3.18 |
| Jun 24, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | Sale | 400 | $30 |
| May 28, 2026 | Maurer Michael T · officer: CHIEF COMMERCIAL OFFICER | A-Award | 80,000 | $29 |
| May 19, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 3,000 | $1.39 |
| May 14, 2026 | Litvack Frank · director | M-Exempt | 3,937 | $1.39 |
| May 4, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 25,000 | $3.18 |
| May 4, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | Sale | 25,000 | $32 |
| May 4, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 25,000 | $3.18 |
| May 4, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | Sale | 25,000 | $32 |
| Apr 3, 2026 | Sabar Karimah Es · director | M-Exempt | 7,529 | $3.18 |
| Apr 3, 2026 | Sabar Karimah Es · director | Sale | 7,529 | $32 |
| Apr 1, 2026 | Sabar Karimah Es · director | M-Exempt | 53,735 | $4.86 |
| Apr 1, 2026 | Sabar Karimah Es · director | Sale | 53,735 | $31 |
| Apr 1, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | Sale | 25,000 | $30 |
| Apr 1, 2026 | Sabar Karimah Es · director | M-Exempt | 61,265 | $4.86 |
| Apr 1, 2026 | Sabar Karimah Es · director | Sale | 61,265 | $30 |
| Apr 1, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 2,819 | $3.18 |
| Apr 1, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 693 | $1.39 |
| Apr 1, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | Sale | 25,000 | $30 |
| Apr 1, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 21,488 | $3.74 |
| Apr 1, 2026 | Bergmann Anthony · officer: CHIEF FINANCIAL OFFICER | M-Exempt | 25,000 | $3.18 |
| Mar 27, 2026 | Krasney Karen · officer: EVP, GENERAL COUNSEL | M-Exempt | 2,500 | $1.39 |
Institutional positioning
13F filings over the trailing two quarters
New 100Increased 140Reduced 82Sold out 33
| Filer | Action | Shares | Filed |
|---|---|---|---|
| BlackRock, Inc. | Increased | 4,145,061 | Aug 7, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 4,099,900 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 4,092,784 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | Increased | 3,818,600 | May 15, 2026 |
| BLACKROCK, INC. | Increased | 3,421,815 | May 13, 2026 |
| TANG CAPITAL MANAGEMENT LLC | Increased | 3,399,900 | May 15, 2026 |
| STATE STREET CORP | Increased | 3,397,150 | Aug 7, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 2,297,674 | Aug 13, 2026 |
| STATE STREET CORP | Increased | 2,181,901 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 2,027,732 | May 15, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Increased | 1,602,162 | Aug 14, 2026 |
| GOLDMAN SACHS GROUP INC | Increased | 1,578,131 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,546,044 | Sep 2, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 1,507,844 | May 15, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | Unchanged | 1,507,844 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jun 29, 2026